HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Sai Life Sciences commence commercial operations of Unit IV Bidar facility in Karnataka
Jun-20-2025

Sai Life Sciences has commenced commercial operation of the second phase of the production block with 91 kL of capacity at its Unit IV Bidar facility in Karnataka, India, on June 19, 2025. This is the second and final phase of the overall capacity addition of 195 kL which was under construction at Unit IV Bidar Facility as disclosed in the prospectus. 

Accordingly, the combined capacity of Unit IV Bidar Facility will be 640 kL which will be equipped to supply registered starting materials (RSM), intermediates, and active pharmaceutical ingredients (APIs) for both clinical and commercial purposes.

Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization.

  RELATED NEWS >>